Aldeyra Therapeutics Announces Advancement of New RASP Modulators and Recent Preclinical Data in Obesity at 2024 Investor Roundtable

--(BUSINESS WIRE)--Aldeyra Therapeutics ... today announced advancement of new RASP modulators and recent preclinical data in obesity in conjunction with an Investor Roundtable scheduled to ... Read More

Dianthus reveals preclinical data for its Phase II neuromuscular candidate

Clinical-stage biotech firm Dianthus Therapeutics has shared ... "Dianthus reveals preclinical data for its Phase II neuromuscular candidate " was originally created and published by Clinical ... Read More

Sionna revives AbbVie’s cystic fibrosis drugs, eyeing a shot at Vertex

The startup says drugs AbbVie abandoned last year could form a combination regimen with “superior efficacy” to Vertex’s market-leading medicines. Read More

Montgomery County woman with cystic fibrosis in need of another double lung transplant after being rejected

they'll get to New York and find the right match. Jen and her mom have their go bags packed, hoping they get the call. Doctors said most patients with cystic fibrosis don't need lung transplants ... Read More

Carisma Therapeutics Announces Nomination of First In Vivo CAR-M Development Candidate for Hepatocellular Carcinoma Under Collaboration with Moderna

Carisma is responsible for the discovery and optimization of development candidates, while Moderna will lead the development and commercialization of resulting therapeutics. Carisma Therapeutics ... Read More

Cognito Therapeutics Announces Scientific Presentations at the Alzheimer’s Association International Conference 2024

Cognito Therapeutics, a leader in technology-based therapeutic interventions for neurodegenerative diseases, today announced that it will present four scientific posters at the Alzheimer’s ... Read More

BCLI Brainstorm Cell Therapeutics Inc.

The company, through its NurOwn proprietary cell ... Brainstorm Cell Therapeutics Inc. was incorporated in 2000 and is headquartered in New York, New York. Read More

AVTE Aerovate Therapeutics, Inc.

Aerovate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops drugs that enhance the lives of patients with rare cardiopulmonary diseases in the United States. It focuses on ... Read More

Thermo Fisher Scientific announces $48M expansion in NKY

Thermo Fisher Scientific will expand its central lab space in the region ... sample management and testing to support new therapeutics, including vaccines and cell and gene therapy products. Read More

A management strategy for producing scientific breakthroughs

New analysis of ... a critical part in producing scientific breakthroughs. This first historical complete analysis of the LMB was carried out by Luka Gebel, Ph.D. candidate at King's Business ... Read More

Aldeyra Therapeutics Announces Advancement of New RASP Modulators and Recent Preclinical Data in Obesity at 2024 Investor Roundtable

We also sell both admissions and sponsorship packages for our investment conferences and advertising ... such as portfolio management or data aggregation. Develop and improve features of our ... Read More

Carisma Therapeutics Announces Nomination of First In Vivo CAR-M Development Candidate for Hepatocellular Carcinoma Under Collaboration with Moderna

Lin Guey, PhD, Chief Scientific Officer of Therapeutics ... candidate for patients with solid tumors, and we look forward to continued success as we develop additional in vivo CAR-M together to ... Read More